TABLE 3.

Data about receiver operating characteristic (ROC) curves to investigate the diagnostic potential of miRNAs on TCGA samples.

Comparison	miRNA	AUC	Sensitivity	Specificity	p-value
NT x BC	miR-142-5p	0.7532	65.86	76.00	<0.0001
	miR-150-5p + miR-142-5p panel	0.9317	88.76	86.67	<0.0001
	miR-142-5p + miR-320a-3p panel	0.7681	52.07	89.33	<0.0001
	miRNAs complete panel*	0.9345	87.68	90.67	< 0.0001
NT x LA	miR-142-5p	0.7371	62.40	76.00	<0.0001
	miR-150-5p + miR-320a-3p panel	0.7458	69.60	70.67	<0.0001
	miR-150-5p + miR-142-5p panel	0.9179	84.80	86.67	<0.0001
	miR-142-5p + miR-320a-3p panel	0.7738	72.00	72.00	<0.0001
	miRNAs complete panel*	0.9266	85.20	90.67	< 0.0001
NT x BLBC	miR-142-5p	0.8671	72.29	93.33	<0.0001
	miR-150-5p + miR-142-5p panel	0.9680	93.90	92.00	<0.0001
	miR-142-5p + miR-320a-3p panel	0.8694	70.73	92.00	<0.0001
	miRNAs complete panel*	0.9689	93.90	92.00	< 0.0001
LA x BLBC	miR-142-5p	0.7220	72.29	67.60	<0.0001
	miR-150-5p + miR-142-5p panel	0.7711	68.67	78.80	<0.0001
	miR-142-5p + miR-320a-3p panel	0.7274	59.04	80.80	<0.0001
	miRNAs complete panel*	0.7728	63.86	80.80	< 0.0001

Only AUC>0.7 is presented. In bold and underlined are the highest AUC values for the group comparison. (*): the four miRNAs were evaluated together. Sensitivity and specificity are presented as percentage (%). BC, breast cancer; NT, non-tumor tissue; LA, luminal A; and BLBC, basal-like breast cancer.